DGAP-News: UMS United Medical Systems International AG: UMS AG Reports on Financial Statements at April 30, 2018


 
DGAP-News: UMS United Medical Systems International AG / Key word(s): Final Results/Miscellaneous UMS United Medical Systems International AG: UMS AG Reports on Financial Statements at April 30, 2018 13.07.2018 / 10:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- UMS AG Reports on Financial Statements at April 30, 2018 Hamburg, July 13, 2018. UMS United Medical Systems International AG i.L. (UMS, ISIN DE 0005493654 / WKN 549365) has reported on the financial statements for the fiscal year from May 1, 2017 to April 30, 2018. The results of ordinary business activities amounted to minus EUR 75k, following EUR 5k in the previous year. Earnings per share were minus 2 Cent per share following 0 Cent per share in fiscal year 2016 / 2017. Liquidity amounted to EUR 2.7 million or 63 Cent per share at balance sheet date following 1.8 million or 41 Cent per share in previous year. This primarily resulted from the special VAT audit that was resolved in company's favour. Equity now amounts to EUR 2.3 million or 55 Cent per share (previous year 2.4 million EUR or 57 Cent per share). Critical for the liquidation going forward is finally the proceeding against the Company's previous tax adviser, Ebner Stolz Wirtschaftsprüfer, Steuerberater, Rechtsanwälte. After the Federal Supreme Court rejected the complaint for failure to grant leave to appeal, the company is in negotiation about the amount of indemnification to pay by the opponent party. The company hopes to successfully finalize the negotiation soon. The UMS AG financial statements for the fiscal year from May 1, 2017 to April 30, 2018 can be downloaded from the Company's website at www.umsag.com. About UMS International AG i.L. UMS International AG i.L. is a corporation listed in the Prime Standard segment of Deutsche Börse AG. The Company sold its interest in United Medical Systems (DE), Inc. and thus essentially all its assets on August 14, 2014. The shareholders agreed to this sale at the special meeting held on September 25, 2014. The agreement was consummated on November 11, 2014. Now that the assets have been sold, the purpose of the Company is to manage its own assets. In addition, the shareholders resolved to dissolve the company as of April 30, 2015. Contact Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail: [email protected] --------------------------------------------------------------------------- 13.07.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: UMS United Medical Systems International AG Borsteler Chaussee 53 22453 Hamburg Germany Phone: +49 (0)40 - 500 177 - 00 Fax: +49 (0)40 - 500 177 - 77 E-mail: [email protected] Internet: www.umsag.com ISIN: DE0005493654 WKN: 549365 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 703865 13.07.2018


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN
©boersengefluester.de
WKN Kurs in € Einschätzung Börsenwert in Mio. €
0,000 0,00
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 0,00
KBV KCV KUV EV/EBITDA
0,00 0,00 0,00 0,00
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,00% 0,00% 0,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu UMS United Medical Systems International AG  ISIN: DE0005493654 können Sie bei EQS abrufen


in Auflösung , 549365